← Leaderboards
Daolin Tang
University Of Pittsburgh At Pittsburgh
$7,044,772
Attributed
$7,660,895
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,660,895 · 4
By mechanism
R01$7,660,895 · 4
Top collaborators
- Timothy R Billiar5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Tomeka L Suber$761,594
- Timothy R Billiar$30,423,539
- James H-C. Wang$6,970,587
- Leo E Otterbein$8,123,287
- Sujean Choi$2,809,771
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingCellsPathway InteractionsRegulationInsightIn VivoInflammationMolecularComplexKnockout MiceIn VitroSmall Hairpin RnaGeneticResponseSignal TransductionGenetic TranscriptionMitochondriaHmgb1 ProteinTumorExtracellularKnock-OutPlayProteinsUp-Regulation
Grant awards (24)
Targeting ACOD1 to attenuate innate immune responses to lethal infections$336,200
R01 · FY2025 · GM · contact PI
Mechanisms of Ferroptotic Cancer Cell Death$353,971
R01 · FY2024 · CA · contact PI
Targeting ACOD1 to attenuate innate immune responses to lethal infections$336,200
R01 · FY2024 · GM · contact PI
Mitophagy in Tumor Microenvironment$381,225
R01 · FY2023 · CA · contact PI
Mechanisms of Ferroptotic Cancer Cell Death$368,905
R01 · FY2023 · CA · contact PI
Targeting ACOD1 to attenuate innate immune responses to lethal infections$336,200
R01 · FY2023 · GM · contact PI
Mitophagy in Tumor Microenvironment$380,062
R01 · FY2022 · CA · contact PI
Mechanisms of Ferroptotic Cancer Cell Death$369,877
R01 · FY2022 · CA · contact PI
Mechanisms of Ferroptotic Cancer Cell Death$376,282
R01 · FY2021 · CA · contact PI
Pathologic Role of Bacterial Cyclic Dinucleotides in Sepsis$283,500
R01 · FY2021 · GM · contact PI
Mitophagy in Tumor Microenvironment$374,553
R01 · FY2019 · CA · contact PI
Mechanisms of Ferroptotic Cancer Cell Death$352,081
R01 · FY2019 · CA · contact PI
Mitophagy in Tumor Microenvironment$339,031
R01 · FY2018 · CA · contact PI
Immunometabolism in Sepsis$316,817
R01 · FY2018 · GM · contact PI
Pathologic Role of Bacterial Cyclic Dinucleotides in Sepsis$283,500
R01 · FY2018 · GM · contact PI
Immunometabolism in Sepsis$2,979
R01 · FY2018 · GM · contact PI
Immunometabolism in Sepsis$304,150
R01 · FY2017 · GM · contact PI
Targeting HMGB1-mediated Autophagy in Cancer Therapy$318,337
R01 · FY2016 · CA · contact PI
Immunometabolism in Sepsis$304,150
R01 · FY2016 · GM · contact PI
Targeting HMGB1-mediated Autophagy in Cancer Therapy$318,337
R01 · FY2015 · CA · contact PI
Immunometabolism in Sepsis$304,150
R01 · FY2015 · GM · contact PI
Targeting HMGB1-mediated Autophagy in Cancer Therapy$308,787
R01 · FY2014 · CA · contact PI
Targeting HMGB1-mediated Autophagy in Cancer Therapy$296,343
R01 · FY2013 · CA · contact PI
Targeting HMGB1-mediated Autophagy in Cancer Therapy$315,258
R01 · FY2012 · CA · contact PI